| Nov 7 |
Compared to Estimates, Qiagen (QGEN) Q3 Earnings: A Look at Key Metrics
|
| Nov 6 |
Qiagen (QGEN) Q3 Earnings and Revenues Top Estimates
|
| Nov 6 |
Qiagen: Q3 Earnings Snapshot
|
| Nov 6 |
Qiagen Non-GAAP EPS of $0.57 beats by $0.02, revenue of $502M beats by $10.88M
|
| Nov 6 |
QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook
|
| Nov 5 |
Qiagen Q3 2024 Earnings Preview
|
| Nov 4 |
QGEN Stock Set to Gain From FDA's Clearance of QIAstat-Dx Mini Panel
|
| Nov 4 |
Qiagen (QGEN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
|
| Nov 4 |
QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics
|
| Oct 29 |
EyePoint Pharmaceuticals (EYPT) Soars 27.6%: Is Further Upside Left in the Stock?
|
